Ibrutinib

  • Part D specialty tier in 80% of formularies (2026Q3)
  • Imbruvica

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Ibrutinib: storage and handling

Freezing
Do not freeze
Label statement
Do not freeze.
Room temperature
at or below 30°C (86°F)
Label statement
Brief exposure to 15°C to 30°C (59°F to 86°F) permitted (see USP Controlled Room Temperature).
Room temperature
at or below 25°C (77°F)
Label statement
Store IMBRUVICA capsules and tablets at room temperature between 68°F and 77°F (20°C and 25°C).
Back into the refrigerator
Not addressed
Light
Protect from light
Label statement
Keep IMBRUVICA tablets in the original carton.
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (at up to 30°C (86°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

Brief exposure to 15°C to 30°C (59°F to 86°F) permitted (see USP Controlled Room Temperature).
Discard any unused IMBRUVICA oral suspension remaining 60 days after first opening the bottle.

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-877-877-3536 (the number printed on the label) about this product.

Where the label prints this number
Call your healthcare provider or 1-877-877-3536 if you need help or have any questions about how to take or give IMBRUVICA the right way.
All storage statements on the label (7)
  • Brief exposure to 15°C to 30°C (59°F to 86°F) permitted (see USP Controlled Room Temperature).
  • Store the oral suspension bottle at 2°C to 25°C (36°F to 77°F).
  • Do not freeze.
  • Discard any unused IMBRUVICA oral suspension remaining 60 days after first opening the bottle.
  • Store IMBRUVICA capsules and tablets at room temperature between 68°F and 77°F (20°C and 25°C).
  • Keep IMBRUVICA tablets in the original carton.
  • Store IMBRUVICA oral suspension bottle between 36°F and 77°F (2°C and 25°C).

FDA label version 65, effective October 21, 2025. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

100%of plans list it
98%of those: prior authorization
0%step therapy
95%quantity limit
97%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.